tiprankstipranks
Trending News
More News >
Avadel Pharmaceuticals (AVDL)
:AVDL
US Market

Avadel Pharmaceuticals (AVDL) Income Statement

Compare
800 Followers

Avadel Pharmaceuticals Income Statement

Last quarter (Q3 2025), Avadel Pharmaceuticals's total revenue was $77.47M, an increase of 54.86% from the same quarter last year. In Q3, Avadel Pharmaceuticals's net income was $20.00K. See Avadel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 169.12M$ 27.96M$ 0.00$ 0.00$ 22.33M
Gross Profit
$ 153.84M$ 27.12M$ 0.00$ 0.00$ 16.59M
Operating Expenses
$ 196.24M$ 164.97M$ 98.56M$ 85.55M$ 10.78M
Depreciation and Amortization
$ 2.68M$ 1.77M$ 1.49M$ 815.00K$ 1.69M
EBITDA
$ -35.57M$ -149.13M$ -97.60M$ -82.39M$ 9.60M
Operating Income
$ -42.40M$ -137.85M$ -98.56M$ -85.55M$ 5.82M
Other Income/Expenses
$ -6.68M$ -22.93M$ -12.88M$ -7.60M$ -10.90M
Pretax Income
$ -49.08M$ -160.78M$ -111.44M$ -93.14M$ -5.08M
Net Income
$ -48.83M$ -160.28M$ -137.46M$ -77.33M$ 7.03M
Per Share Metrics
Basic EPS
$ -0.51$ -2.00$ -2.29$ -1.32$ 0.13
Diluted EPS
$ -0.51$ -2.00$ -2.29$ -1.32$ 0.13
Weighted Average Shares Outstanding
95.14M 80.17M 60.09M 58.53M 53.00M
Weighted Average Shares Outstanding (Diluted)
95.14M 80.17M 60.09M 58.53M 54.94M
Currency in USD

Avadel Pharmaceuticals Earnings and Revenue History